AstraZeneca’s diabetes drug Onglyza is associated with higher risk of premature death and heart failure, a preliminary report released Friday by the U.S. This medication comes as a tablet and must be taken on a regular basis to be most effective. Prescribing Information for adult type 2 diabetes patients. If you or a loved one took Onglyza and suffered severe complications, you may have grounds for a lawsuit against the manufacturer, AstraZeneca AB, and would benefit from speaking with an experienced Long Island Onglyza lawsuit lawyer. In 2014 alone, Onglyza sales reached $820 million. Patients and family members who have suffered injuries as a result of taking Onglyza may be entitled to compensation in the form of wrongful death expenses, punitive damages, medical costs, pain and suffering and lost wages. However, two large clinical trials conducted in patients with heart disease, scientists found that more patients taking these types of drugs were hospitalized for heart failure compared to patients who received a placebo.
Onglyza was approved for sale in the U.S. The medication brought in approximately $820 million in 2014 alone. As a result, physicians and pharmaceutical companies are looking for safer alternatives to treat Type 2 diabetes, and it is believed that incretin mimetics hold promise in this area. However, Onglyza and other incretin mimetics are only intended to treat diabetes symptoms, like frequent urination and thirst. The large, international study involved nearly 16,500 patients with type 2 diabetes from 26 countries. FDA staff reviewers not only flagged a potential risk of heart failure, but staffers also identified an increase in the rate of “all-cause mortality” among the Onglyza patients in that trial. Fewer than 5% of patients diagnosed with pancreatic cancer survive beyond five years.
If you do not know whether you are already on this type of medication, ask your doctor. The most commonly used first drug in the treatment plan is Metformin. The lawsuits were filed based on the claims that the drug maker failed to indicate that the medication could affect the pancreas. In response to these lawsuits, the FDA ordered an investigation that studied whether or not there was a link between taking Onglyza and pancreatitis. These investigations found that there was, indeed, a correlation between an increased risk of pancreatitis/pancreatic cancer and Onglyza. There is no cost or obligation to speak with us, and any information you provide will be kept confidential. We now know that Onglyza can dramatically increase the risk of congestive heart failure.
In 2011, it was found that a Victoza, a medication that acts very similarly to Onglyza, did, in fact, lead to an increased chance of the development of thyroid cancer on rodents who were treated with the medication. Additionally, another study that was conducted at the University of California, Los Angeles, stated that people who used the medication were much more likely to develop thyroid cancer than those who did not take it. In 2013, a study published in the New England Journal of Medicine stated that patients who took Onglyza had an increased chance of being hospitalized as a result of heart failure than those who did not take the medication. 16, 2006 through Dec. Because of the severity of this condition, people who are diagnosed with heart failure must make drastic changes to their lifestyle in order to maintain their health. As a result of the increased risk of heart failure while taking Onglyza, many lawsuits have been filed against AstraZeneca, the makers of the medication. The role of saxagliptin is to increase the quantity of two-incretin hormones located in the body called glucagon-like peptides-1 and glucose-dependent insulinotropic peptide.
Given the findings that the Type 2 Diabetes medication Onglyza has been linked to causing the aforementioned medical conditions, including thyroid cancer, pancreatitis, pancreatic cancer and heart failure, financial combination may be available in the form of a personal injury claim or Onglyza class actions lawsuit for individuals diagnosed with one of these conditions. These lawsuits are based on the premise that the manufacturer of the medication did not provide warning of the potential health risks that it could cause, and withheld important safety information from both the medical community and consumers. As a result of the many findings that link this medication to serious health risks, including death, countless law firms are encouraging those individuals who have been prescribed the medication and who have developed medical conditions that have been linked to the medication, including severe joint pain, thyroid cancer, heart failure, pancreatitis and pancreatic cancer, to seek legal assistance. These law firms are helping individuals seek compensation for the damages that they have suffered as a result of taking Onglyza, including the medical expenses they have incurred, loss of wages as a result of lost time at work, pain and suffering and more. If you or someone you love has developed heart failure, pancreatitis, pancreatic cancer, thyroid cancer or any other medical condition that may be linked to the use of Onglyza, you may be able to file a lawsuit against the makers of the drug, AstraZeneca. In order to find out if you have a viable case against the makers of the Onglyza, you should know your legal rights. Contact a law firm to find out more.